Is oral pulsed prednisolone useful in alopecia areata? Critical appraisal of a randomized trial [13] (multiple letters)

Journal of the American Academy of Dermatology

Volumn 53, Issue 6, 2005, Pages 1100-1101

  Sladden, Michael J ^a   Hutchinson, Peter E ^a   Handa, Sanjeev ^b,c  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b Postgraduate Institute of Medical Education and Research   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ACNE; ALOPECIA AREATA; ASEPTIC NECROSIS; BONE DENSITY; CLINICAL FEATURE; CLINICAL TRIAL; DRUG PULSE THERAPY; DRUG SAFETY; GLAUCOMA; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; STATISTICAL ANALYSIS; WEIGHT GAIN;

EID: 27944480037     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.07.056     Document Type: Letter

References (3)

1. B.R. Kar S. Handa S. Dogra B. Kumar Placebo-controlled oral pulse prednisolone therapy in alopecia areata J Am Acad Dermatol 52 2005 287 290
2. M.A. Weinstock The JAAD adopts the CONSORT statement J Am Acad Dermatol 41 1999 1045 1047
3. M. Sladden S. MacDonald Hull M. Wood P. Hutchinson A. Messenger Alopecia areata: the need for guidelines and evidence-based dermatology Br J Dermatol 152 2005 1086 1087